Nuzenio

Supn

Supn news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Strong-Buy at Zacks Research - MarketBeatMarketBeat · Sat, 08 Aug 2026 11:44:17 GMTSupernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Hold" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:18:55 GMTAre BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders? - PR NewswirePR Newswire · Fri, 07 Aug 2026 21:06:00 GMTSUPN vs. TEVA: Which Stock Should Value Investors Buy Now? - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 15:40:02 GMTSUPN Aug 2026 65.000 call (SUPN260821C00065000) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 15:21:11 GMTSupernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN - Business WireBusiness Wire · Fri, 07 Aug 2026 15:21:00 GMTMillennium group (SUPN) reports Supernus stake falls below 5% ownership - Stock TitanStock Titan · Thu, 06 Aug 2026 22:49:12 GMTSupernus Pharmaceuticals (SUPN) Jumps On Merger Terms, Is The Stock Still Cheap? - simplywall.stsimplywall.st · Thu, 06 Aug 2026 06:36:02 GMT

Timeline

Sat, 08 Aug 2026 11:44:17 GMTSupernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Sat, 08 Aug 2026 05:18:55 GMTSupernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Hold" at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 21:06:00 GMTAre BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders? - PR Newswire
Fri, 07 Aug 2026 15:40:02 GMTSUPN vs. TEVA: Which Stock Should Value Investors Buy Now? - Yahoo Finance
Fri, 07 Aug 2026 15:21:11 GMTSUPN Aug 2026 65.000 call (SUPN260821C00065000) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fri, 07 Aug 2026 15:21:00 GMTSupernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Supn.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.